Tag: bayer ag

Bayer’s Kerendia demonstrates success in phase 3 clinical trials for treatment of heart failure

byPhilip Heand1 others

October 3, 2024

A phase 3 trial showed Kerendia reduced the risk of cardiovascular death by 16% compared to placebo. Hyperkalemia was greater ...

Quick Take: Intimate Partner Homicide of Adolescents

Bayer AG: Elinzanetant Shows Promise In Treating Menopause-Associated Vasomotor Symptoms In Phase 3 Clinical Trials

byUsamah Bhaiduand1 others

May 29, 2024

Elinzanetant reduced the frequency and severity of menopause-associated vasomotor symptoms in two phase 3 clinical trials. Elinzanetant was safe and ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

Tag: bayer ag

Bayer’s Kerendia demonstrates success in phase 3 clinical trials for treatment of heart failure

Bayer AG: Elinzanetant Shows Promise In Treating Menopause-Associated Vasomotor Symptoms In Phase 3 Clinical Trials

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits